Total employment in the Massachusetts life sciences industry remained effectively flat in 2024, a noteworthy slowdown for a cornerstone sector after more than a decade of steady growth.

After 13 straight years of increased employment in the Bay State’s life sciences sector, 2024 data shows stagnancy.

We expect this trend to continue, as the firm continues to scale their new life sciences segment both through organic investment and acquisitions. Our main concern is the threat that increased ...

Even though the growth of Massachusetts' life sciences industry has slowed down and faces looming federal funding challenges, ...

FUJIFILM Corporation's Life Sciences Group companies, a portfolio of businesses offering products, services and comprehensive ...

FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences and FUJIFILM Diosynth Biotechnologies will be known as FUJIFILM ...

The investment is one of the largest in UK life sciences history and comes with up to £129m in government support. It forms part of the government’s Plan for Change, aimed at accelerating growth in ...

Jayant Narlikar’s greatest quality was his ability to convey the most abstract ideas about the cosmos, physics, and science to the ... The university sector is now at the forefront of using ...

A "landmark" investment of up to £1billion in the British life sciences sector will turbocharge drug discovery and research into mRNA vaccines, the Science Secretary has announced. German Covid ...

Highlights,STERIS’ fiscal projections for future earnings adjusted slightly downward.,The company operates within the healthcare and life sciences sectors.,Market evaluation reflects stable ...

The projects have the potential to deliver around 10 million square feet of workspace and labs, and deliver vital investment in digital and technologies and the life sciences sectors - two of the key ...

A Massachusetts-based wound care and sports medicine company announced plans for its brand-new biomanufacturing facility Tuesday in Smithfield. Trump administration issues major COVID vaccine ...